DNA damage and repair: From molecular mechanisms to health implications

Antioxidants and Redox Signaling

Volumn 10, Issue 5, 2008, Pages 891-937

  Altieri, Fabio ^a   Grillo, Caterina ^a   Maceroni, Manola ^a   Chichiarelli, Silvia ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BRCA1 PROTEIN; CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; DACARBAZINE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; LOMUSTINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; METHYLNITRONITROSOGUANIDINE; METHYLNITROSOUREA; MITOMYCIN C; NITROSOUREA; OXALIPLATIN; PROCARBAZINE; PROTEIN MLH1; PROTEIN MSH2; REACTIVE OXYGEN METABOLITE; TAXANE DERIVATIVE; TEMOZOLOMIDE; UNINDEXED DRUG; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

AGING; ATAXIA TELANGIECTASIA; BLOOM SYNDROME; BREAST CANCER; CANCER SUSCEPTIBILITY; CERNUNNOS SYNDROME; COCKAYNE SYNDROME; COLON POLYP; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; DNA SYNTHESIS; DOUBLE STRANDED DNA BREAK; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME SPECIFICITY; EXCISION REPAIR; FANCONI ANEMIA; GENE MUTATION; GENETIC DISORDER; GENOMIC INSTABILITY; HUMAN; LIG4 SYNDROME; MISMATCH REPAIR; MUIR TORRE SYNDROME; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; OMENN SYNDROME; PRIORITY JOURNAL; PROGERIA; PROSTATE CANCER; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; ROTHMUND THOMSON SYNDROME; SECKEL SYNDROME; SEVERE COMBINED IMMUNODEFICIENCY; SINGLE STRANDED DNA BREAK; TREATMENT OUTCOME; TRICHOTHIODYSTROPHY; TURCOT SYNDROME; WERNER SYNDROME; XERODERMA PIGMENTOSUM;

ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; DNA; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA REPAIR-DEFICIENCY DISORDERS; FREE RADICALS; HUMANS; MOLECULAR STRUCTURE;

EID: 39749151090     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1830     Document Type: Review

References (270)

1. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, and Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 13: 356-361, 2007.
2. Aas PA, Otterlei M, Falnes PØ, Vågbø CB, Skorpen F, Akbari M, Sundheim O, Bjørås M, Slupphaug G, Seeberg E, and Krokan HE. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421: 859-863, 2003.
3. Abdel-Rahman WM, Mecklin JP, and Peltomaki P. The genetics of HNPCC: application to diagnosis and screening. Crit Rev Oncol Hematol 58: 208-220, 2006.
4. Abraham J, Earl HM, Pharoah PD, and Caldas C. Pharmacogenetics of cancer chemotherapy. Biochim Biophys Acta 1766: 168-183, 2006.
5. Abraham RT. PI 3-kinase related kinases: "big" players in stress-induced signaling pathways. DNA Repair (Amst) 3: 883-887, 2004.
6. Ahmed M and Rahman N. ATM and breast cancer susceptibility. Oncogene 25: 5906-5911, 2006.
7. Ahnesorg P, Smith P, and Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124: 301-313, 2006.
8. Amor-Gueret M. Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis. Cancer Lett 236: 1-12, 2006.
9. Andressoo JO, Hoeijmakers JH, and Mitchell JR. Nucleotide excision repair disorders and the balance between cancer and aging. Cell Cycle 5: 2886-2888, 2006.
10. Andressoo JO, Mitchell JR, de Wit J, Hoogstraten D, Volker M, Toussaint W, Speksnijder E, Beems RB, van Steeg H, Jans J, de Zeeuw CI, Jaspers NG, Raams A, Lehmann AR, Vermeulen W, Hoeijmakers JH, and van der Horst GT. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell. 10: 121-132, 2006.
11. Araujo SJ, Nigg EA, and Wood RD. Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Mol Cell Biol 21: 2281-2291, 2001.
12. Arnaudeau C, Lundin C, and Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells. J Mol Biol 307: 1235-1245, 2001.
13. Audebert M, Salles B, and Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 279: 55117-55126, 2004.
14. Barnes DE and Lindhal T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 38: 445-476, 2004.
15. Bartek J and Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 19: 238-245, 2007.
16. Batty DP and Wood RD. Damage recognition in nucleotide excision repair of DNA. Gene 241: 193-204, 2000.
17. Bebenek K and Kunkel TA. Functions of DNA polymerases. Adv Protein Chem 69: 137-165, 2004.
18. Bewick MA, Conlon MS, Lafrenie RM. Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 24: 5645-5651, 2006.
19. Bignami M, Casorelli I, and Karran P. Mismatch repair and response to DNA-damaging antitumor therapies. Eur J Cancer 39: 2142-2149, 2003.
20. Bochkareva E, Belegu V, Korolev S, and Bochkarev A. Structure of the major single-stranded DNA-binding domain of replication protein A suggests a dynamic mechanism for DNA binding. EMBO J 20: 612-618, 2001.
21. Bogliolo M., Lyakhovich A, Callen E, Castellà M, Cappelli E, Ram̧re MJ, Creus A, Marcos R, Kalb R, Neveling K, Schindler D, and Surralles J. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26: 1340-1351, 2007.
22. Bohr VA, Ottersen OP, and Tonjum T. Genome instability and DNA repair in brain, ageing and neurological disease. Neuroscience 145: 1183-1186, 2007.
23. Boudsocq F, Benaim P, Canitrot Y, Knibiehler M, Ausseil F, Capp JP, Bieth A, Long C, David B, Shevelev I, Frierich-Heinecken E, Hubscher U, Amalric F, Massiot G, Hoffmann JS, and Cazaux C. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta. Mol Pharmacol 67: 1485-1492, 2005.
24. Brooks BP, Kleta R, Stuart C, Tuchman M, Jeong A, Stergiopoulos SG, Bei T, Bjornson B, Russell L, Chanoine JP, Tsagarakis S, Kalsner L, and Stratakis C. Genotypic heterogeneity and clinical phenotype in triple A syndrome: a review of the NIH experience 2000-2005. Clin Genet 68: 215-221, 2005.
25. Buck D, Malivert L, de Chasseval R, Barraud A, Fondaneche MC, Sanal O, Plebani A, Stephan JL, Hufnagel M, le Deist F, Fischer A, Durandy A, de Villartay JP, and Revy P. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124: 287-299, 2006.
26. Buck D, Moshous D, de Chasseval R, Ma Y, Le Deist F, Cavazzana-Calvo M, Fischer A, Casanova JL, Lieber MR, and De Villartay JP. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 36: 224-235, 2006.
27. Bugreev DV, Mazina OM, and Mazin AV. Rad54 protein promotes branch migration of Holliday junctions. Nature 442: 590-593, 2006.
28. Bunick CG and Chazin WJ. Two blades of the exscissor. Structure 13: 1740-1741, 2005.
29. Bunick CG, Miller Mr, Fuller BE, Fanning E, and Chazin VJ. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein. Biochemistry 45: 14965-14979, 2006.
30. Cadet J, Douki T, Gasparutto D, and Ravanat JL. Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531: 5-23, 2003.
31. Cadet J, Sage E, and Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 571: 3-17, 2005.
32. Caldecott KW. Mammalian DNA single-strand break repair: an X-ra(y)ted affair. Bioessays 23: 447-455, 2001.
33. Cannavo E, Gerrits B, Marra B, Schlapbach R, and Jiricny J. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J Biol Chem 282: 2976-2986, 2007.
34. Cannavo E, Marra G, Sabates-Bellver J, Menigatti M, Lipkin SM, Fischer F, Cejka P, and Jiricny J. Expression of the MutL homologue hMLH3 in human cells and its role in DNA mismatch repair. Cancer Res 65: 10759-10766, 2005.
35. Casali P, Pal Z, Xu Z, and Zan H. DNA repair in antibody somatic hypermutation. Trends Immunol 27: 313-321, 2006.
36. Chalmers AJ. Poly(ADP-ribose) polymerase-1 and ionizing radiation: sensor, signaler and therapeutic target. Clin Oncol (R Coll Radiol) 16: 29-39, 2004.
37. Charara M, Edmonston TB, Burkholder S, Walters R, Anne P, Mitchell E, Fry R, Boman B, Rose D, Fishel R, Curran W, and Palazzo J. Micro satellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res 24: 3161-3167, 2004.
38. Choi YJ, Ryu KS, Ko YM, Chae YK, Pelton JG, Wemmer DE, and Choi BS. Biophysical characterization of the interaction domains and mapping of the contact residues in the XPF-ERCC1 complex. J Biol Chem 280: 28644-28652, 2005.
39. Christmann M, Tomicic MT, Ross WP, and Kaina B. Mechanisms of human DNA repair: an update. Toxicology 193: 3-34, 2003.
40. Chung SJ and Verdine GL. Structure of end products resulting from lesion processing by a DNA glycosylase/lyase. Chem Biol 11: 1643-1649, 2004.
41. Ciccia A, Ling C, Coulthard R, Yan Z, Xue Y, Meetei AR, Laghmani el H, Joenje H, McDonald N, de Winter JP, Wang W, and West SC. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 25: 331-343, 2007.
42. Cleaver JE. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5: 564-573, 2005.
43. Collins AR, Cadet J, Möller L, Poulsen HE, and Viña J. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Arch Biochem Biophys 423: 57-65, 2004.
44. Collis SJ, DeWeese TL, Jeggo PA, and Parker AR. The life and death of DNA-PK. Oncogene 24: 949-961, 2005.
45. Constantin N, Dzantiev L, Kadyrov FA, and Modrich P. Human mismatch repair: reconstitution of a nick-directed bidirectional reaction. J Biol Chem 280: 39752-39761, 2005.
46. Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, Hickson ID, and West SC. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep 1: 80-84, 2000.
47. D'Amours D and Jackson SP. The MRE11 complex: at the crossroads of DNA repair and check signalling. Nat Rev Mol Cell Biol 3: 317-327, 2002.
48. D'Errico M, Parlanti E, Teson M, Degan P, Lemma T, Calcagnile A, Iavarone I, Jaruga P, Ropolo M, Pedrini AM, Orioli D, Frosina G, Zambruno G, Dizdaroglu M, Stefanini M, and Dogliotti E. The role of CSA in the response to oxidative DNA damage in human cells. Oncogene 26: 4336-4343, 2007.
49. Das A, Wiederhold L, Leppard JB, Kedar P, Prasad D, Wang H, Boldogh I, Karimi-Busheri F, Weinfeld M, Tomkinson AE, Wilson SH, Mitra S, and Hazra TK. NEIL2-initiated, APE-independent repair of oxidized bases in DNA: evidence for a repair complex in human cells. DNA Repair (Amst) 5: 1439-1448, 2006.
50. Daughdrill GW, Buchko GW, Botuyan MV, Arrowsmith C, Wold MS, Kennedy MA, and Lowry DF. Chemical shift changes provide evidence for overlapping single-stranded DNA- and XPA-binding sites on the 70 kDa subunit of human replication protein A. Nucleic Acids Res. 31: 4176-4183, 2003.
51. Davies SL, North PS, Dart A, Lakin ND, and Hickson ID. Phosphorylation of the Bloom's syndrome helicase and its role in recovery from S-phase arrest. Mol Cell Biol 24: 279-291, 2004.
52. De Boer J and Hoeijmakers JHJ. Nucleotide excision repair and human syndromes. Carcinogenesis 21: 453-460, 2000.
53. de Jager M, van Noort J, van Gent DC, Dekker C, Kanaar R, and Wyman C. Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol Cell 8: 1129-1135, 2001.
54. De Soto JA and Deng CX. PARP-1 inhibitors: Are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers? Int J Med Sci 3: 117-123, 2006.
55. Demple B and Sung JS. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst) 4: 1442-1449, 2005.
56. Denver DR, Swenson SL, and Lynch M. An evolutionary analysis of the helix-hairpin-helix superfamily of DNA repair glycosylases. Mol Biol Evol 20: 1603-1611, 2003.
57. Di Santo R and Maga G. Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy. Curr Med Chem 13: 2353-2368, 2006.
58. Ding J, Miao ZH, Meng LH, and Geng MY. Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci 27: 338-344, 2006.
59. Dip R, Camenisch U, and Naegeli H. Mechanisms of DNA damage recognition and strand discrimination in human nucleotide excision repair. DNA Repair (Amst) 3: 1409-1423, 2004.
60. Dizdaroglu M, Jaruga P, Birincioglu M, and Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 32: 1102-1115, 2002.
61. Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 591: 45-59, 2005.
62. Dogru-Abbasoglu S, Aykac-Toker G, Hanagasi HA, Gurvit H, Emre M, and Uysal M. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurol Sci 28: 31-34, 2007.
63. Downs JA and Cote J. Dynamics of chromatin during the repair of DNA double-strand breaks. Cell Cycle 4: 1373-1376, 2005.
64. Dunand-Sauthier I, Hohl M, Thorel F, Jaquier-Gubler P, Clarkson SG, and Scharer OD. The spacer region of XPG mediates recruitment to nucleotide excision repair complexes and determines substrate specificity. J Biol Chem 280: 7030-7037, 2005.
65. Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, and Sedgwick B. Reversal of DNA alkylation damage by two human dioxygenases. Proc Natl Acad Sci U S A 99: 16660-16665, 2002.
66. Dzantiev L, Constantin N, Genschel J, Iyer RR, Burgers PM, and Modrich P. A defined human system that supports bidirectional mismatch-provoked excision. Mol Cell 15: 31-41, 2004.
67. Efferth T and Volm M. Pharmacogenetics for individualised cancer chemotherapy. Pharmacol Ther 107: 155-176, 2005.
68. Ege M, Ma Y, Manfras B, Kalwak K, Lu H, Lieber MR, Schwarz K, and Pannicke U. Omenn syndrome due to ARTEMIS mutations. Blood 105: 4179-4186, 2005.
69. El-Khamisy SF, Saifi GM, Weinfeld M, Johansson F, Helleday T, Lupski JR, Caldecott KW. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 434: 108-113, 2005.
70. Enders A, Fisch P, Schwarz K, Duffner U, Pannicke U, Nikolopoulos E, Peters A, Orlowska-Volk M, Schindler D, Friedrich W, Selle B, Niemeyer C, and Ehl S. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 176: 5060-5068, 2006.
71. Evans M and Cooke M. Oxidative damage to nucleic acids. Georgetown, TX: Landes Biosciences, 2007, pp. 1-13.
72. Evans MD, Dizdaroglu M, and Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567: 1-61, 2004.
73. Fan J and Wilson DM III. Protein-protein interaction and post-translational modifications in mammalian base excision repair. Free Radic Biol Med 38: 1121-1138, 2005.
74. Fan L, Arvai AS, Cooper PK, Iwai S, Hanaoka F, and Tainer JA Conserved XPB core structure and motifs for DNA unwinding: implications for pathway selection of transcription or excision repair. Mol Cell 22: 27-37, 2006.
75. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, and Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005.
76. Fedier A and Fink D. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity. Int J Oncol 24: 1039-1047, 2004.
77. Fedier A, Schwarz VA, Walt H, Carpini RD, Haller U, and Fink D. Resistance to topoisomerase poisons due to loss of DNA mismatch repair. Int J Cancer 93: 571-576, 2001.
78. Fischer JL, Mihelc EM, Pollok KE, and Smith ML. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair. Mol Cancer Ther 6: 355-361, 2007.
79. Fishel ML, Vasko MR, and Kelley MR. DNA repair in neurons: so if they don't divide what's to repair? Mutat Res 614: 24-36, 2007.
80. Flores-Rozas H, Clark D, and Kolodner RD. Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex. Nat Genet 26: 375-378, 2000.
81. Fortini P and Dogliotti E. Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. DNA Repair (Amst) 6: 398-409, 2007.
82. Fortune JM and Osheroff N. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol 64: 221-253, 2000.
83. Fousteri M, Vermeulen W, van Zeeland AA, and Mullenders LH. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Mol Cell 23: 471-482, 2006.
84. Frappart PO and McKinnon PJ. Ataxia-telangiectasia and related diseases. Neuromol Med 8: 495-512, 2006.
85. Friedberg EC, Lehmann AR, and Fuchs RP. Trading places: how do DNA polymerases switch during translesion DNA synthesis? Mol Cell 18: 499-505, 2005.
86. Fujkawa K, Yakushiji H, Nakabeppu Y, Suzuki T, Masuda M, Ohshima H, and Kasai H. 8-Cloro-dGTP, a HOCl-modified nucleotide, is hydrolyzed by hMTH1, the human MutT homolog. FEBS Lett 512: 149-151, 2002.
87. Galkin VE, Esashi F, Yu X, Yang S, West SC, and Egelman EH. BRCA2 BRC motifs bind RAD51-DNA filaments. Proc Natl Acad Sci U S A 102: 8537-8542, 2005.
88. Gedik CM and Collins A. ESCODD (European Standards Committee on Oxidative DNA Damage): establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J 19: 82-84, 2005.
89. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem 71: 101-132, 2002.
90. Genschel J and Modrich P. Mechanism of 5′-directed excision in human mismatch repair. Mol Cell 12: 1077-1086, 2003.
91. Genschell J, Littman SJ, Drummond JT, and Modrich P. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutS-. J Biol Chem 273: 19895-19901, 1998.
92. Gervais V, Lamour V, Jawhari A, Frindel F, Wasielewski E, Dubaele S, Egly JM, Thierry JC, Kieffer B, and Poterszman A. TFIIH contains a PH domain involved in DNA nucleotide excision repair. Nat Struct Mol Biol 11: 616-622, 2004.
93. Giles GI and Sharma RP. Topoisomerase enzymes as therapeutic targets for cancer chemotherapy. Med Chem 1: 383-394, 2005.
94. Girard PM, Kysela B, Harer CJ, Doherty AJ, and Jeggo PA. Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms. Hum Mol Genet 13: 2369-2376, 2004.
95. Gorgels TG, van der Pluijm I, Brandt RM, Garinis GA, van Steeg H, van den Aardweg G, Jansen GH, Ruijter JM, Bergen AA, van Norren D, Hoeijmakers JH, and van der Horst GT. Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Mol Cell Biol 27: 1433-1441, 2007.
96. Gradia S, Acharya S, and Fishel R. The role of mismatched nucleotides in activating the hMSH2-hMSH6 molecular switch. Cell 91: 995-1005, 1997.
97. Graham JM Jr, Anyane-Yeboa K, Raams A, Appeldoorn E, Kleijer WJ, Garritsen VH, Busch D, Edersheim TG, and Jaspers NG. Cerebro-oculo-facio- skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. Am J Hum Genet 69: 291-300, 2001.
98. Greenberg RA, Sobhian B, Pathania S, Cantor SB, Nakatani Y, and Livingston DM. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes Dev 20: 34-46, 2006.
99. Halliwell B and Gutteridge JM. Cellular response to oxidative stress: adaptation, damage, repair, senescence and death in free radical in biology and medicine. Oxford: Oxford University Press, 2007, pp. 187-267.
100. Hanawalt PC. Subpathways of nucleotide excision repair and their regulation. Oncogene 21: 8949-8956, 2002.
101. Hazra TK, Das A, Das S, Choudhury S, Kow YW, and Roy R. Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst) 6: 470-480, 2007.
102. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundan T, Mannermaa A, Borresen-Dale AL, Borg A, Barkardottir RB, Petrini J, and Winqvist R. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 27: 1593-1959, 2006.
103. Helleday T, Bryant HE, and Schultz N. Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination and as a target for cancer therapy. Cell Cycle 4: 1176-1178, 2005.
104. Helleday T, Lo J, van Gent DC, Engelward BP. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6: 923-935, 2007.
105. Hickson ID. RecQ helicases: caretakers of the genome. Nat Rev Cancer 3: 169-178, 2003.
106. Hirano M, Furiya Y, Asai H, Yasui A, and Ueno S. ALADIN I482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci U S A 103: 2298-2303, 2006.
107. Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Majid S, Vejdani K, and Dahiya R. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer 43: 231-237, 2007.
108. Hitomi K, Iwai S, and Tainer JA. The intricate structural chemistry of base excision repair machinery: implications for DNA damage recognition, removal, and repair. DNA Repair (Amst) 6: 410-428, 2007.
109. Hochegger H, Dejsuphong D, Fukushima T, Morrison C, Sonoda E, Schreiber V, Zhao GY, Saberi A, Masutani M, Adachi N, Koyama H, De Murcia G, and Takeda S. Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertrebate cells. EMBO J 25: 1305-1314, 2006.
110. Hoeijmakers JHJ. Genomic maintenance mechanisms for preventing cancer. Nature 411: 366-374, 2001.
111. Honig M and Schwarz K. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation. Curr Opin Rheumatol 18: 383-388, 2006.
112. Hopfner KP, Karcher A, Craig L, Woo TT, Carney JP, and Tainer JA. Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell 105: 473-485, 2001.
113. Huffman JL, Sundheim O, and Tainer JA. DNA base damage recognition and removal: new twists and grooves. Mutat Res 577: 55-76, 2005.
114. Ikegami T, Kuraoka I, Saijo M, Kodo N, Kyogoku Y, Morikawa K, Tanaka K, and Shirakawa M. Solution structure of the DNA-and RPA-binding domain of the human repair factor XPA. Nat Struct Mol Biol 5: 701-706, 1998.
115. Ishibashi T, Hayakawa H, and Sekivuchi M. A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides. EMBO Rep 4: 479-483, 2003.
116. Iyer RR, Pluciennik A, Burdett V, and Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev 106: 302-323, 2006.
117. Izumi T, Wiederhold LR, Roy G, Roy R, Jaiswal A, Bhakat KK, Mitra S, and Hazra TK. Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 193: 43-65, 2003.
118. Jacob S, Aguado M, Fallik D, and Praz F. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Res 61: 6555-6562, 2001.
119. Jagtap P and Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov 4: 421-440, 2005.
120. Jascur T and Boland CL. Structure and function of the components of the human DNA mismatch repair system. Int J Cancer 119: 2030-2035, 2006.
121. Jaspers NG, Raams A, Silengo MC, Wijgers N, Niedernhofer LJ, Robinson AR, Giglia-Mari G, Hoogstraten D, Kleijer WJ, Hoeijmakers JH, and Vermeulen W. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio- skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet 80: 457-466, 2007.
122. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7: 335-346, 2006.
123. Jun SH, Kim TG, and Ban C. DNA mismatch repair system classical and fresh roles. FEBS J 273: 1609-1619, 2006.
124. Kadyrov F, Dzantiev L, Constantin N, and Modrich P. Endonucleolytic function of MutLalpha in human mismatch repair. Cell 126: 297-308, 2006.
125. Kamory E, Tanyi M, Kolacsek O, Olasz L, Toth L, Damjanovich L, and Csuka O. Two germline alterations in mismatch repair genes found in a HNPCC patient with poor family history. Pathol Oncol Res 12: 228-233, 2006.
126. Karimi-Busheri F, Daly G, Robins P, Canas B, Pappin DJ, Sgouros J, Miller GG, Fakhrai H, Davis EM, Le Beau MM, and Weinfeld M. Molecular characterization of a human DNA kinase. J Biol Chem 274: 24187-24194, 1999.
127. Karow JK, Constantinou A, Li JL, West SC, and Hickson ID. The Bloom's syndrome gene product promotes branch migration of Holliday junctions. Proc Natl Acad Sci U S A 97: 6504-6508, 2000.
128. Karran P. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22: 1931-1937, 2001.
129. Kelley MR and Parsons SH. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1. Antioxid Redox Signal 3: 671- 683, 2001.
130. Kietthubthew S, Sriplung H, Au WW, and Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209: 21-29, 2006.
131. Killoran MP and Keck JL. Sit down, relax and unwind: structural insights into RecQ helicase mechanisms. Nucleic Acids Res 34: 4098-4105, 2006.
132. Kim B, Ryu KS, Kim HJ, Cho SJ, and Choi BS. Solution structure and backbone dynamics of the XPC-binding domain of the human DNA repair protein hHR23B. FEBS J 272: 2467-2476, 2005.
133. Knaapen AM, Güngör N, Schins RP, Borm PJ, and Van Shooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21: 225-236, 2006.
134. Koch CA, Agyei R, Galicia S, Metalnikov P, O'Donnell P, Starostine A, Weinfeld M, and Durocher D. Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. EMBO J 23: 3874-3885, 2004.
135. Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, and Digiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 145: 1388-1396, 2007.
136. Krokan HE, Standal R, and Slupphaug G. DNA glycosylases in the base excision repair of DNA. Biochem J 325: 1-16, 1997.
137. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, and Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 15: 6662-6670, 1996.
138. Kunkel TA and Erie DA. DNA mismatch repair. Annu Rev Biochem 74: 681-710, 2005.
139. Kunkel TA. The high cost of living. Trends Genet 15: 93-94, 1999.
140. Kurz EU and Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3: 889-900, 2004.
141. Kusumoto R, Masutani C, Sugasawa K, Iwai S, Araki M, Uchida A, Mizukoshi T, and Hanaoka F. Diversity of the damage recognition step in the global genomic nucleotide excision repair in vitro. Mutat Res 485: 219-227, 2001.
142. Kusumoto R, Muftuoglu M, and Bohr VA. The role of WRN in DNA repair is affected by post-translational modifications. Mech Ageing Dev 128: 50-57, 2007.
143. Kyng KJ, May A, Kolvraa S, and Bohr VA. Gene expression profiling in Werner syndrome closely resembles that of normal aging. Proc Natl Acad Sci U S A 100: 12259-12264, 2003.
144. Lagerstedt Robinson K, Liu T, Vandrovcova J, Halvarsson B, Clendenning M, Frebourg T, Papadopoulos N, Kinzler KW, Vogelstein B, Peltomaki P, Kolodner RD, Nilbert M, and Lindblom A. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 99: 291-299, 2007.
145. Lainé JP and Egly JM. Initiation of DNA repair mediated by a stalled RNA polymerase II. EMBO J 25: 387-397, 2006.
146. Landi S, Gemignani F, Canzian F, Gaborieau V, Barale R, Landi D, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gioia-Patricola L, Hall J, Boffetta P, Hung RJ, and Brennan P. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 66: 11062-11069, 2006.
147. Larsen E, Kwon K, Coin F, Egly JM, and Klungland A. Transcription activities at 8-oxoG lesions in DNA. DNA Repair (Amst) 3: 1457-1468, 2004.
148. Lau PJ and Kolodner RD. Transfer of the MSH2.MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA. J Biol Chem 278: 14-17, 2003.
149. Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, and Cooper PK. Retraction of: Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, and Cooper PK. Cell 101, 159-171, 2000. Cell 123: 711, 2005.
150. Lee BI and Wilson III DM. The RAD2 domain of human exonuclease 1 exhibits 5′ to 3′ exonuclease and flap structure-specific endonuclease activities. J Biol Chem 274: 37763-37769, 1999.
151. Lee JH, Park CJ, Arunkumar AI, Chazin WJ, and Choi BS. NMR study on the interaction between RPA and DNA decamer containing cis-syn cyclobutane pyrimidine dimer in the presence of XPA: implication for damage verification and strand-specific dual incision in nucleotide excision repair. Nucleic Acids Res 31: 4747-4754, 2003.
152. Lee KB, Wang D, Lippard SJ, and Sharp PA. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc Natl Acad Sci U S A 99: 4239-4244, 2002.
153. Lehmann AR. Translesion synthesis in mammalian cells. Exp Cell Res 312: 2673-2676, 2006.
154. Liu Y, Masson JY, Shah R, O'Regan P, and West SC. RAD51C is required for Holliday junction processing in mammalian cells. Science 303: 243-246, 2004.
155. Lockett KL, Snowhite IV, and Hu JJ. Nucleotide-excision repair and prostate cancer risk. Cancer Lett 220: 125-135, 2005.
156. Lombard DB, Chua KF, Mostoslavsky R, Franco S, Gostissa M, and Alt FW. DNA repair, genome stability, and aging. Cell 120: 497-512, 2005.
157. Ma Y, Lu H, Tippin B, Goodman MF, Shimazaki N, Koiwai O, Hsieh CL, Schwarz K and Lieber MR. A biochemically defined system for mammalian nonhomologous DNA end-joining. Mol Cell 16: 701-713, 2004.
158. Ma Y, Pannicke U, Schwarz K, and Lieber MR. Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108: 781-794, 2002.
159. Ma Y, Schwarz K, and Lieber MR. The Artemis: DNA-PKcs endonuclease cleaves DNA loops, flaps, and gaps. DNA Repair 4: 845-851, 2005.
160. Mace G, Briot D, Guervilly JH, and Rosselli F. Fanconi anemia: cellular and molecular features. Pathol Biol 55: 19-28, 2007.
161. Madhusudan S and Middleton MR. The emerging role of DNA repair proteins as predictive prognostic and therapeutic target in cancer. Cancer Treat Rev 31: 603-617, 2005.
162. Maizels N. Immunoglobulin gene diversification. Annu Rev Genet 39: 23-46, 2005.
163. Mari PO, Florea BI, Persengiev SP, Verkaik NS, Brüggenwirth HT, Modesti M, Giglia-Mari G, Bezstarosti K, Demmers JAA, Luider TM, Houtsmuller AB, and van Gent DC. Dynamic assembly of end joining complexes requires interaction between Ku70/80 and XRCC4. Proc Natl Acad Sci U S A 103: 18597-18602, 2006.
164. Marrella V, Poliani PL, Casati A, Rucci F, Frascoli L, Gougeon ML, Lemercier B, Bosticardo M, Ravanini M, Battaglia M, Roncarolo MG, Cavazzana-Calvo M, Facchetti F, Notarangelo LD, Vezzoni P, Grassi F, and Villa A. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest 117: 1260-1269, 2007.
165. Marti TM, Kunz C, and Fleck O. DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191: 28-41, 2002.
166. Martin GM, Austad SN, and Johnson TE. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet 13: 25-34, 1996.
167. McCulloch SD, Gu L, and Li GM. Bi-directional processing of DNA loops by mismatch repair-dependent and -independent pathways in human cells J Biol Chem 278: 3891-3896, 2003.
168. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I,. Mathew CG, Hoatlin M, Joenje H, de Winter JP, and Wang W. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37: 958-963, 2005.
169. Mellon I. Transcription-coupled repair: a complex affair. Mutat Res 577: 155-161, 2005.
170. Meyers M, Wagner MW, Hwang HS, Kinsella TJ, and Boothman DA. Role of the hMLHl DNA mismatch repair protein in 5-fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res 61: 5193-5201, 2001.
171. Mirchandani KD and D'Andrea AD. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res 312: 2647-2653, 2006.
172. Modrich P. Mechanisms in eukaryotic mismatch repair. J Biol Chem 281: 30305-30309, 2006.
173. Moreno-Herrero F, de Jager M, Dekker NH, Kanaar R, Wyman C, and Dekker C. Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA. Nature 437: 440-443, 2005.
174. Mosedale G, Niedzwiedz W, Alpi A, Perrina F, Pereira-Leal JB, Johnson M, Langevin F, Pace P, and Patel KJ. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol 12: 763-771, 2005.
175. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186, 2001.
176. Muller A and Fishel R. Mismatch repair and the hereditary nonpolyposis colorectal cancer syndrome (HNPCC). Cancer Invest 20: 102-109, 2002.
177. Nick McElhinny SA, Havener JM, Garcia-Diaz M, Juarez R, Bebenek K, Kee BL, Blanco L, Kunkel TA and Ramsden DA. A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous
178. Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, Odijk H, Oostendorp R, Ahmad A, van Leeuwen W, Theil AF, Vermeulen W, van der Horst GT, Meinecke P, Kleijer WJ, Vijg J, Jaspers NG, and Hoeijmakers JH. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444: 1038-1043, 2006.
179. Niida H and Nakanishi M. DNA damage checkpoint in mammals. Mutagenesis 21: 3-9, 2006.
180. Nishi R, Okuda J, Watanabe E, Mori T, Iwai S, Masutani C, Sugasawa K, and Hanaoka F. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein. Mol Cell Biol 25: 5664-5674, 2005.
181. Nookala RK, Hussain S, and Pellegrini L. Insights into Fanconi anaemia from the structure of human FANCE. Nucleic Acids Res 35: 1638-1648, 2007.
182. Norris AM, Woodruff RD, D'Agostino RB Jr, Clodfelter JE, and Scarpinato KD. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer. Prostate 67: 214-225, 2007.
183. O'Driscoll M, Gennery AR, Seidel J, Concannon P, and Jeggo PA. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATRSeckel syndrome. DNA Repair (Amst) 3: 1227-1235, 2004.
184. Ohshima H, Sawa T, and Akaike T. 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 8: 1033-1045, 2006.
185. Okano S, Lan L, Caldecott KW, Mori T, and Yasui A. Spatial and temporal cellular responses to single-strand breaks in human cells. Mol Cell Biol 23: 3974-3981, 2003.
186. Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, Thithapandha A, and Hongeng S. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 48: 16-20, 2007.
187. Park CJ and Choi BS. The protein shuffle: sequential interactions among components of the human nucleotide excision repair pathway. FEBS J 273: 1600-1608, 2006.
188. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, and Lenz HJ. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy inpatients with advanced colorectal cancer. Cancer Res 61: 8654-8658, 2001.
189. Pascucci B, Maga G, Hubscher U, Bjoras M, Seeberg E, Hickson ID, Villani G, Giordano C, Cellai L, and Dogliotti E. Reconstitution of the base excision repair pathway for 7,8-dihydro-8-oxoguanine with purified human proteins. Nucleic Acids Res 30: 2124-2130, 2002.
190. Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A, Shani A, Schechtman E, Freedman L, and Livneh Z. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer. Cancer Res 66: 11683-11689, 2006.
191. Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 462: 83-100, 2000.
192. Perry JJ, Fan L, and Tainer JA. Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair. Neuroscience 145: 1280-1299, 2007.
193. Pfeifer GP, You YH, and Besaratinia A. Mutations induced by ultraviolet light. Mutat Res 571: 19-31, 2005.
194. Pichierri P and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J 23: 1178-1187, 2004.
195. Pichierri P, Franchitto A, and Rosselli F. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. Eur Mol Biol Org J 23: 3154-3163, 2004.
196. Plosky BS and Woodgate, R. Switching from high-fidelity to low-fidelity lesion-bypass polymerases. Curr Opin Genet Dev 14: 113-119, 2004
197. Pommier Y, Redon C, Rao VA, Seiler JA, Sordet O, Takemura H, Antony S, Meng L,.Liao Z, Kohlhagen G, Zhang H, and Kohn KW. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat Res 532: 173-203, 2003.
198. Rabik CA and Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33: 9-23, 2007.
199. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D. Breast cancer susceptibility collaboration (UK), Easton DF, and Stratton MR. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39: 165-167, 2007.
200. Raschle M, Marra G, Nystrom-Lahti M, Schar P, and Jiricny J. Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1. J Biol Chem 274: 32368-32375, 1999.
201. Ravanat JL, Douki T, and Cadet J. Direct and indirect effects of UV radiation on DNA and its components. J Photochem Photobiol B Biol 63: 88-102, 2001.
202. Raymond E, Chaney SG, Taamma A, Cvitkovic E. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol 9: 1053-1071, 1998.
203. Raynard S, Bussen W, and Sung P. A double Holliday junction dissolvasome comprising BLM, topoisomerase III alpha, and BLAP75. J Biol Chem 281: 13861-13864, 2006.
204. Reddy MC and Vasquez KM. Repair of genome destabilizing lesions. Radiat Res 164: 345-356, 2005.
205. Reddy YV, Ding Q, Lees-Miller SP, Meek K, and Ramsden DA. Non-homologous end joining requires that the DNA-PK complex undergo an autophosphorylation- dependent rearrangement at DNA ends. J Biol Chem 279: 39408-39413, 2004.
206. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, Neveling K, Kelly P, Seal S, Freund M, Wurm M, Batish SD, Lach FP, Yetgin S, Neitzel H, Ariffin H, Tischkowitz M, Mathew CG, Auerbach AD, and Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39: 162-164, 2007.
207. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K, McGuffog L, Evans DG, Eccles D, Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR, and Rahman N. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38: 873-875, 2006.
208. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, Recio MJ, Reis C, Dahm K, Fricke A, Krempler A, Parker AR, Jackson SP, Gennery A, Jeggo PA, and Lobrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol Cell 16: 715-724, 2004.
209. Riedl T, Hanaoka F, and Egly JM. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J 22: 5293-5303, 2003.
210. Rooney S, Chaudhuri J, and Alt FW. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol Rev 200: 115-131, 2004.
211. Russo MT, Blasi MF, Chiera F, Fortini P, Degan P, Macpherson P, Furuichi M, Nakabeppu Y, Karran P, Aquilina G, and Bignami M. The oxidized deoxynucleoside triphosphate pool is a significant contributor to genetic instability in mismatch repair-deficient cells. Mol Cell Biol 24: 465-474, 2004.
212. Ryu JS, Hong YC, Han HS, Lee JE, Kim S, Park YM, Kim YC, and Hwang TS. Association between polymorphisms of ERCC1 and XPD and survival in non-small cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer 44: 311-316, 2004.
213. Sarasin A and Stary A. New insights for understanding the transcription-coupled repair pathway. DNA Repair (Amst) 6: 265-269, 2007.
214. Sarker AH, Tsutakawa SE, Kostek S, Ng C, Shin DS, Peris M, Campeau E, Tainer JA, Nogales E, and Cooper PK. Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne syndrome. Mol Cell 20: 187-198, 2005.
215. Sasai K, Akagi T, Aoyanagi E, Tabu K, Kaneko S, and Tanaka S. O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glyoma therapies. Mol Cancer 6: 36-44, 2007.
216. Schreiber V, Dantzer F, Amé JC, and De Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Mol Cell Biol 7: 517-527, 2006.
217. Sekiguchi M, Nakabeppu Y, Sakumi K, and Tuzuki T. DNA repair methyltransferase as a molecular device for preventing mutation and cancer. J Cancer Res Clin Oncol 122: 199-206, 1996.
218. Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M, and Chauffert B. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins. Cancer Chemother Pharmacol 49: 445-452, 2002.
219. Sharma S, Doherty KM, and Brosh RM Jr. Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem J 398: 319-337, 2006.
220. Shin DS, Chahwan C, Huffman JL, and Tainer JA. Structure and function of the double strand break repair machinery. DNA Repair (Amst) 3: 863-873, 2004.
221. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER 3rd, Hurov KE, Luo J, Ballif BA, Gygi SP, Hofmann K, D'Andrea AD, and Elledge SJ. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129: 289-301, 2007.
222. Spagnolo L, Rivera-Calzada A, Pearl LH, Llorca O. Three-dimensional structure of the human DNA-PKcs/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell 22: 511-519, 2006.
223. Steinacher R and Schar P. Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Curr Biol 15: 616-623, 2005.
224. Stivers JT and Jiang YL. A mechanistic perspective on the chemistry of DNA repair glycosylases. Chem Rev 103: 2729-2759, 2003.
225. Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, Park D, and Lenz HJ. A polymorphism of XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 21: 3075-3079, 2001.
226. Stracker TH, Theunissen JW, Morales M, and Petrini JH. The MRE11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair 3: 845-854, 2004.
227. Su TT. Cellular response to DNA damage: one signal, multiple choices. Annu Rev Genet 40: 187-208, 2007.
228. Subba Rao K. Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Pract Neurol 3: 162-172, 2007.
229. Sugasawa K, Okuda J, Saijo M, Nishi R, Matsuda N, Chu G, Mori T, Iwai S, Tanaka K, and Hanaoka F. UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 121: 387-400, 2005.
230. Sung JS and Demple B. Roles of base excision repair subpathways in correcting oxidized abasic sites in DNA. FEBS J 273: 1620-1629, 2006.
231. Surtees JA, Argueso JL, and Alani E. Mismatch repair proteins: key regulators of genetic recombination. Cytogenet Genome Res 107: 146-159, 2004.
232. Szyf M. DNA methylation and cancer therapy. Drug Resist Update 6: 341-353, 2003.
233. Takahashi T, Tada M, Igarashi S, Koyama A, Date H, Yokoseki A, Shiga A, Yoshida Y, Tsuji S, Nishizawa M, and Onodera O. Aprataxin, causative gene product for AEOH/AOA1, repairs DNA single-strand breaks with damaged 3′-phosphate and 3′-phosphoglycolate ends. Nucleic Acids Res 35: 3797-3809, 2007.
234. Taniguchi T and D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107: 4223-4233, 2006.
235. Tauchi H, Matsuura S, Kobayashi J, Sakamoto S, and Komatsu K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene 21: 8967-8980, 2002.
236. Taylor AM, Groom A, and Byrd PJ. Ataxia-telangiectasia-like disorder (ATLD): its clinical presentation and molecular basis. DNA Repair (Amst) 3: 1219-1225, 2004.
237. Tell G, Damante G, Caldwell D, and Kelley MR. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 7: 367-384, 2005.
238. Thoms KM, Kuschal C, and Emmert S. Lessons learned from DNA repair defective syndromes. Exp Dermatol 16: 532-544, 2007.
239. Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, and Foulkes WD. Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci U S A 104: 6788-6793, 2007.
240. Valentini AM, Armentano R, Pirrelli M, and Caruso ML. Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art. Cancer Treat Rev 32: 607-618, 2006.
241. Valerie K and Povirk LF. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22: 5792-5812, 2003.
242. van Attikum H and Gasser SM. The histone code at DNA breaks: a guide to repair? Nat Rev Mol Cell Biol 6: 757-765, 2005.
243. van der Burg M, van Veelen LR, Verkaik NS, Wiegant WW, Hartwig NG, Barendregt BH, Brugmans L, Raams A, Jaspers NG, Zdzienicka MZ, van Dongen JJ, and van Gent DC. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 116: 137-145, 2006.
244. Venkitaraman AR. Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat Rev Cancer 4: 266-276, 2004.
245. Verdine GL and Norman DP. Covalent trapping of protein-DNA complexes. Annu Rev Biochem 72: 337-366, 2003.
246. Vernole P, Pepponi R, and D'Atri S. Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents. Cancer Chemother Pharmacol 52: 185-192, 2003.
247. Vo AT, Zhu F, Wu X, Yuan F, Gao Y, Gu L, Li GM, Lee TH, and Her C. hMRE11 deficiency leads to microsatellite instability and defective DNA mismatch repair. EMBO Rep 6: 438-444, 2005.
248. Volker M, Mone MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W, Hoeijmakers JH, van Driel R, van Zeeland AA, and Mullenders RH. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 8: 213-224, 2001.
249. Walsh T and King MC. Ten genes for inherited breast cancer. Cancer Cell 11: 103-105, 2007.
250. Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, and King MC. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295: 1379-1388, 2006.
251. Wang JY and Edelmann W. Mismatch repair proteins as sensors of alkylation DNA damage. Cancer Cell 9: 417-418, 2006.
252. Wang M, Wu W, Wu W, Rosidi B, Zhang L, Wang H and Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 34: 6170-6182, 2006.
253. Wang QE, Zhu Q, Wani G, El-Mahdy MA, Li J, and Wani AA DNA repair factor XPC is modified by SUMO-1 and ubiquitin following UV irradiation. Nucleic Acids Res 33: 4023-4034, 2005.
254. Wang X, Andreassen PR, and D'Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/ FANCD1 in chromatin. Mol Cell Biol 24: 5850-5862, 2004.
255. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939, 2000.
256. Weterings E, Verkaik NS, Bruggenwirth HT, Hoeijmakers JH, and van Gent DC. The role of DNA dependent protein kinase in synapsis of DNA ends. Nucleic Acids Res 31: 7238-7246, 2003.
257. Whitby MC. Making crossovers during meiosis. Biochem Soc Trans 33:1451-1455, 2005.
258. Wilson III DM and Bohr VA. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair (Amst) 6: 544-559, 2007.
259. Wilson III DM. Properties of and substrate determinants for the exonuclease activity of human apurinic endonuclease Ape1. J Mol Biol 330: 1027-1037, 2003.
260. Wood RD, Mitchell M, and Lindhal T. Human DNA repair genes. Mutat Res 577: 275-283, 2005.
261. Wyman C and Kanaar R. DNA double-strand break repair: all's well that ends well. Annu Rev Genet 40: 363-383, 2006.
262. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, and de Winter JP. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39: 159-161, 2007.
263. Yan T, Berry SE, Desai AB, and Kinsella TJ. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR proficient RKO cells. Clin Cancer Res 9: 2327-2334, 2003.
264. Yang Y and Herrup K. Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta 1772: 457-466, 2007.
265. Young LC, Hays JB, Tron VA, and Andrew SE. DNA mismatch repair proteins: potential guardians against genomic instability and tumorigenesis induced by ultraviolet photoproducts. J Invest Dermatol 121: 435-440, 2003.
266. Yuan F, Gu L, Guo S, Wang C, and Li GM. Evidence for involvement of HMGB1 protein in human DNA mismatch repair. J Biol Chem 279: 20935-20940, 2004.
267. Zha S, Alt FW, Cheng HL, Brush JW, and Li G. Defective DNA repair and increased genomic instability in Cernunnos-XLF-deficient murine ES cells. Proc Natl Acad Sci U S A 104: 4518-4123, 2007.
268. Zhang Y, Yuan F, Presnell SR, Tian K, Gao J, Tomkinson AE, Gu L, and Li GM. Reconstitution of 5′-directed human mismatch repair in a purified system. Cell 122: 693-705, 2005.
269. Zheng D, Li T, Liu X, Hu W, Chen H, and Yang Y. A novel MSH2 mutation in a Chinese family with hereditary non-polyposis colorectal cancer. Int J Colorectal Dis 22: 875-879, 2007.
270. Zhou J, Lim CU, Li JJ, Cai L, and Zhang Y. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage. Cancer Lett 243: 9-15, 2006.